Article Versions Notes

Maillet D, Allioli N, Péron J, Plesa A, Decaussin-Petrucci M, Tartas S, Sajous C, Ruffion A, Crouzet S, Freyer G, et al. Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer. Cancers. 2021; 13(23):6014. https://doi.org/10.3390/cancers13236014

Maillet, Denis, Nathalie Allioli, Julien Péron, Adriana Plesa, Myriam Decaussin-Petrucci, Sophie Tartas, Christophe Sajous, Alain Ruffion, Sébastien Crouzet, Gilles Freyer, and et al. 2021. "Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer" Cancers 13, no. 23: 6014. https://doi.org/10.3390/cancers13236014

Maillet, D., Allioli, N., Péron, J., Plesa, A., Decaussin-Petrucci, M., Tartas, S., Sajous, C., Ruffion, A., Crouzet, S., Freyer, G., & Vlaeminck-Guillem, V. (2021). Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer. Cancers, 13(23), 6014. https://doi.org/10.3390/cancers13236014